annual CAPEX:
$8.91M+$7.60M(+582.08%)Summary
- As of today (September 14, 2025), BBIO annual capital expenditures is $8.91 million, with the most recent change of +$7.60 million (+582.08%) on December 31, 2024.
- During the last 3 years, BBIO annual CAPEX has fallen by -$39.34 million (-81.54%).
- BBIO annual CAPEX is now -81.54% below its all-time high of $48.25 million, reached on December 31, 2021.
Performance
BBIO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$5.09M+$3.50M(+219.37%)Summary
- As of today (September 14, 2025), BBIO quarterly capital expenditures is $5.09 million, with the most recent change of +$3.50 million (+219.37%) on June 30, 2025.
- Over the past year, BBIO quarterly CAPEX has increased by +$2.65 million (+108.17%).
- BBIO quarterly CAPEX is now -87.71% below its all-time high of $41.46 million, reached on September 30, 2021.
Performance
BBIO quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$11.66M+$2.65M(+29.38%)Summary
- As of today (September 14, 2025), BBIO TTM capital expenditures is $11.66 million, with the most recent change of +$2.65 million (+29.38%) on June 30, 2025.
- Over the past year, BBIO TTM CAPEX has increased by +$6.85 million (+142.62%).
- BBIO TTM CAPEX is now -76.09% below its all-time high of $48.76 million, reached on June 30, 2022.
Performance
BBIO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BBIO CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +582.1% | +108.2% | +142.6% |
3 y3 years | -81.5% | +30.6% | -76.1% |
5 y5 years | +73.4% | +1372.3% | +67.7% |
BBIO CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -81.5% | +582.1% | at high | >+9999.0% | -76.1% | +792.6% |
5 y | 5-year | -81.5% | +582.1% | -87.7% | >+9999.0% | -76.1% | +792.6% |
alltime | all time | -81.5% | +1819.8% | -87.7% | >+9999.0% | -76.1% | +792.6% |
BBIO CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $5.09M(+219.4%) | $11.66M(+29.4%) |
Mar 2025 | - | $1.59M(-50.7%) | $9.01M(+1.2%) |
Dec 2024 | $8.91M(+582.1%) | $3.24M(+86.9%) | $8.91M(+45.9%) |
Sep 2024 | - | $1.73M(-29.2%) | $6.11M(+27.1%) |
Jun 2024 | - | $2.45M(+64.0%) | $4.80M(+72.5%) |
Mar 2024 | - | $1.49M(+243.0%) | $2.79M(+113.3%) |
Dec 2023 | $1.31M(-79.3%) | $435.00K(+0.9%) | $1.31M(-21.9%) |
Sep 2023 | - | $431.00K(+0.7%) | $1.67M(-16.4%) |
Jun 2023 | - | $428.00K(+3466.7%) | $2.00M(-63.5%) |
Mar 2023 | - | $12.00K(-98.5%) | $5.47M(-13.4%) |
Dec 2022 | $6.32M(-86.9%) | $801.00K(+5.5%) | $6.32M(-21.5%) |
Sep 2022 | - | $759.00K(-80.5%) | $8.06M(-83.5%) |
Jun 2022 | - | $3.90M(+354.2%) | $48.76M(+3.4%) |
Mar 2022 | - | $859.00K(-66.1%) | $47.14M(-2.3%) |
Dec 2021 | $48.25M | $2.54M(-93.9%) | $48.25M(+0.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $41.46M(+1712.9%) | $47.86M(+589.3%) |
Jun 2021 | - | $2.29M(+16.6%) | $6.94M(+38.8%) |
Mar 2021 | - | $1.96M(-8.6%) | $5.00M(-33.5%) |
Dec 2020 | $7.52M(+46.3%) | $2.15M(+290.9%) | $7.52M(+5.6%) |
Sep 2020 | - | $549.00K(+58.7%) | $7.12M(+2.4%) |
Jun 2020 | - | $346.00K(-92.3%) | $6.95M(-3.3%) |
Mar 2020 | - | $4.48M(+156.3%) | $7.19M(+39.9%) |
Dec 2019 | $5.14M(-71.7%) | $1.75M(+358.5%) | $5.14M(+51.5%) |
Sep 2019 | - | $381.00K(-34.6%) | $3.39M(-6.2%) |
Jun 2019 | - | $583.00K(-76.0%) | $3.62M(-22.9%) |
Mar 2019 | - | $2.43M(+301.2%) | $4.69M(-73.1%) |
Dec 2018 | $18.18M(+3817.7%) | - | - |
Sep 2018 | - | $605.00K(-63.4%) | $17.44M(+3.6%) |
Jun 2018 | - | $1.66M(-89.1%) | $16.83M(+10.9%) |
Mar 2018 | - | $15.18M | $15.18M |
Dec 2017 | $464.00K | - | - |
FAQ
- What is BridgeBio Pharma, Inc. annual capital expenditures?
- What is the all time high annual CAPEX for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual CAPEX year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly capital expenditures?
- What is the all time high quarterly CAPEX for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly CAPEX year-on-year change?
- What is BridgeBio Pharma, Inc. TTM capital expenditures?
- What is the all time high TTM CAPEX for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. TTM CAPEX year-on-year change?
What is BridgeBio Pharma, Inc. annual capital expenditures?
The current annual CAPEX of BBIO is $8.91M
What is the all time high annual CAPEX for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual capital expenditures is $48.25M
What is BridgeBio Pharma, Inc. annual CAPEX year-on-year change?
Over the past year, BBIO annual capital expenditures has changed by +$7.60M (+582.08%)
What is BridgeBio Pharma, Inc. quarterly capital expenditures?
The current quarterly CAPEX of BBIO is $5.09M
What is the all time high quarterly CAPEX for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly capital expenditures is $41.46M
What is BridgeBio Pharma, Inc. quarterly CAPEX year-on-year change?
Over the past year, BBIO quarterly capital expenditures has changed by +$2.65M (+108.17%)
What is BridgeBio Pharma, Inc. TTM capital expenditures?
The current TTM CAPEX of BBIO is $11.66M
What is the all time high TTM CAPEX for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high TTM capital expenditures is $48.76M
What is BridgeBio Pharma, Inc. TTM CAPEX year-on-year change?
Over the past year, BBIO TTM capital expenditures has changed by +$6.85M (+142.62%)